A share price of Abeona Therapeutics Inc [ABEO] is currently trading at $5.31, up 1.14%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ABEO shares have gain 4.12% over the last week, with a monthly amount glided 9.48%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Oppenheimer started tracking the stock with Outperform rating on March 05, 2025, and set its price target to $16. On July 03, 2024, H.C. Wainwright initiated with a Buy rating and assigned a price target of $15 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $21 on May 30, 2024. Cantor Fitzgerald upgraded its rating to a Overweight but $4 remained the price target by the analyst firm on November 11, 2020. B. Riley FBR started tracking with a Buy rating for this stock on September 18, 2020, and assigned it a price target of $5. In a note dated February 10, 2020, SVB Leerink initiated an Outperform rating and provided a target price of $6 on this stock.
Abeona Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $3.93 and $7.54. Currently, Wall Street analysts expect the stock to reach $14 within the next 12 months. Abeona Therapeutics Inc [NASDAQ: ABEO] shares were valued at $5.31 at the most recent close of the market. An investor can expect a potential return of 163.65% based on the average ABEO price forecast.
Analyzing the ABEO fundamentals
Gross Profit Margin for this corporation currently stands at -2.41% with Operating Profit Margin at -208.02%, Pretax Profit Margin comes in at 206.66%, and Net Profit Margin reading is 205.88%. To continue investigating profitability, this company’s Return on Assets is posted at 0.36, Equity is 0.78 and Total Capital is -0.4. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Abeona Therapeutics Inc [NASDAQ:ABEO] is 9.74. Further, the Quick Ratio stands at 9.53, while the Cash Ratio is 3.75. Considering the valuation of this stock, the price to sales ratio is 719.38, the price to book ratio is 1.62 and price to earnings (TTM) ratio is 4.56.
Transactions by insiders
Recent insider trading involved Seshadri Vishwas, Chief Executive Officer, that happened on Dec 29 ’25 when 25000.0 shares were sold. Officer, Seshadri Vishwas completed a deal on Dec 29 ’25 to buy 25000.0 shares. Meanwhile, Director Alvino Mark sold 15000.0 shares on Nov 13 ’25.
